(Q24816546)

5 July 2017

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-alpha2beta and Ribavirin (English)

1 reference

5 July 2017

1 reference

Huy A Tran

1

1 reference

5 July 2017

Tracey L Jones

series ordinal

2

1 reference

5 July 2017

Robert G Batey

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

12 October 2005

1 reference

5 July 2017

BMC Endocrine Disorders

1 reference

5 July 2017

5

1 reference

5 July 2017

1

0 references

page(s)

8

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6823-5-8

5 July 2017

0 references

cites work

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

5: Diagnosis and management of hyperthyroidism and hypothyroidism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

Interferon-alpha and autoimmune thyroid disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

The epidemiology of thyroid disease and implications for screening

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

Side effects of high-dose interferon therapy for chronic hepatitis C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1266361

Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-5-8

Thyroid disorders in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-5-8

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-5-8

The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-5-8

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6823-5-8

Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection

21 January 2018

1 reference

12 December 2020

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

12 December 2020

Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis

1 reference

12 December 2020

Population survey of thyroid autoimmunity in Italy. Three year follow up

1 reference

12 December 2020

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy

1 reference

12 December 2020

Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6823-5-8

1 reference

Dimensions Publication ID

5 July 2017

0 references

1 reference

5 July 2017

1 reference